Astrana Health ASTH Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $30.99M+28.7% | $24.08M— | —— | —— | —— | ||
| $54.38M+18.9% | $45.75M+22.1% | $37.47M+28.6% | $29.14M-1.8% | $29.68M+6.3% | ||
| $40.69M+5.4% | $38.6M-9.1% | $42.45M+3.8% | $40.92M+11.8% | $36.6M+6.0% | ||
| $168.91M+43.8% | $117.48M— | —— | —— | —— | ||
| $11.04M+9.2% | $10.11M+5.6% | $9.57M+2.8% | $9.32M-13.2% | $10.73M+33.6% | ||
| —— | $548.6M-5.3% | $579.32M+1,729% | $31.68M-66.9% | $95.61M-34.6% | ||
| -$539.45M-0.1% | -$539M+5.6% | -$571.27M-1,172% | -$44.9M+63.7% | -$123.75M+35.7% | ||
| $2.53M-67.9% | $7.89M-4.4% | $8.25M-1.5% | $8.37M-10.9% | $9.4M+133% | ||
| —— | —— | —— | —— | $473.88M+176% | ||
| $79.02M-84.0% | $495.29M+1.7% | $487.07M+11.0% | $438.86M-1.7% | $446.55M+2,314% | ||
| $623.89M+4.7% | $595.68M— | —— | —— | —— | ||
| —— | —— | $115.69M+704% | $14.39M+119% | -$76.28M-1,410% | ||
| $160.94M+45.7% | $110.44M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Astrana Health's cash flow data come from?
- Every line is extracted from Astrana Health's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.